Fuse Medical Q2 2023 net income $307,588 vs loss of $322,936 a year ago

Fuse Medical, Inc.

Revenue rose 7% to $5.0M from $4.7M in Q2 2022.
Gross profit grew 31% to $3.5M (69% margin) from $2.6M (57% margin).
SG&A expense increased to $1.6M from $1.4M; commissions down slightly.
EBITDA swung to $401,574 from a loss of $246,834 year-over-year.
CEO cites growth from portfolio of Fuse branded/manufactured products and national distribution expansion.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Fuse Medical, Inc. reported second quarter ending June 30, 2023 results: revenue $5.0 million, net income $307,588.

Period: second quarter ending June 30, 2023
Revenue: $5.0 million
Net income: $307,588
Result: reported results

Exact text from the filing

quarter ended June 30, 2023 with the Securities and Exchange Commission (“SEC”). Second Quarter 2023 Financial Highlights ● Net revenues for the quarter ended June 30, 2023 were $5.0 million, compared to $4.7 million for the quarter ended June 30, 2022 which was an increase of approximately 7%. ● For the quarter ended June 30, 2023, gross profit was $3.5 million, or

View on SEC.gov

Browse all earnings releases →

Fuse Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-023797

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.